Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx NextG UCITS ETF 14.04.2026 NXTG.LN IE00BWTNM743 170,002.00 USD 7,659,654.89 45.056  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Dow Jones International Internet UCITS ETF 14.04.2026 FDNI.LN IE00BT9PVG14 425,002.00 USD 7,893,265.75 18.572  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 14.04.2026 UIGB IE00079WNSI6 2,591.00 GBP 66,529.33 25.677  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 14.04.2026 UNCU.LN IE00BD6GCF16 801,374.00 USD 36,068,639.96 45.009  ...

SINGAPORE & INNSBRUCK, Austria--(BUSINESS WIRE)--Horizon Quantum Computing Pte. Ltd., the wholly-owned subsidiary of Horizon Quantum Holdings Ltd. (Nasdaq: HQ “Horizon Quantum”), a pioneer of software infrastructure for quantum applications, and AQT (Alpine Quantum Technologies), a leading European provider of trapped-ion quantum computers, today announced a strategic collaboration to advance the development of real-world quantum computing applications via increased hardware-software integratio...

LONDON--(BUSINESS WIRE)--The gap between office construction volumes in London and New York City reached a record high in the second half of 2025, according to data from CoStar, a global leading provider of online real estate marketplaces, information and analytics in the property markets. Over 16m sq. ft. of office space was under construction in London at the end of last year, more than 10m sq. ft. above the comparable figure in New York (5.7m sq. ft.), marking the largest differential in Lon...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Income UCITS ETF 14.04.2026 UINC IE00BZBW4Z27 9,984,104.00 USD 374,115,789.37 37.471  ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) announced today that it will host a live webcast on Wednesday, April 29 at 8:30 a.m. Eastern Time to discuss its first quarter 2026 financial results and highlight progress on key programs. The webcast may be accessed at https://ir.ionis.com/events-and-presentations/upcoming-events. A replay will be available for a limited time at the same address. About Ionis Pharmaceuticals, Inc. For three decades, Ionis has invente...

BOSTON--(BUSINESS WIRE)--Elucid announced today the commercial availability of a new Lesion Inspection Tool for coronary and carotid plaque analysis in its novel Plaque-IQ software suite. The tool provides physicians the ability to interrogate lesion-specific composition and plaque burden across any vessel, which can help the physician better understand the patient risk profile to enhance clinical decision-making. “The Lesion Inspection Tool provides a detailed view of plaque composition at the...

DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced that it has received Clinical Trial Application (CTA) approval to expand the ongoing global ELIMINATE-B clinical trial of PBGENE-HBV. The regulatory authorization will allow Precision to initiate important hepatitis B clinical trial sites in France a...